MedTrace Logo

Vecuronium Requirements According to the Operation Phase During Liver Transplantation Under Desflurane Anesthesia

NCT01379352 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2013-12-25

No results posted yet for this study

Summary

The vecuronium requirements may be reduced for recipients of living donor liver transplantation, as the vecuronium is eliminated principally by the liver. Furthermore, the requirements may be different according to the phase of surgery. The requirements may also be different according to the preoperative hepatic function as measured by MELD score during prehepatic phase, or graft to recipient body weight ratio (GRWR) during neohepatic phase. Therefore, the investigators are trying to investigate the difference of vecuronium requirements according to the phase of surgery or MELD score, GRWR.

Conditions

  • Liver Transplantation

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Gaab Soo Kim, M.D.,Ph.D. · Samsung Medical Center

Eligibility

Min Age
20 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01379352 on ClinicalTrials.gov